Exclusive: Perceptic Aims to Automate Drug Discovery
Perceptic, a London-founded startup formed by former Palantir Life Sciences executives, launches from stealth with a ...
Glide paths in target date funds describe how asset allocations shift automatically as retirement nears, balancing growth and risk over time. This intro explains the idea and why it matters for planning.
25,488 articlesPerceptic, a London-founded startup formed by former Palantir Life Sciences executives, launches from stealth with a ...
Mastercard is expanding its crypto settlement rails to include a variety of dollar-pegged tokens, with ripple’s rlusd...
The 2026 COLA boosted Social Security checks, yet a fixed Medicare premium cut into those gains, changing how retiree...
A bold move from SpaceX has investors weighing risk and reward. This guide breaks down what the decision could mean f...
Public feuds grab headlines and dollars alike. This article uses the Katie Price reignites Victoria moment to show pr...
Trump unveils a plan to monetize passage through the Strait of Hormuz, triggering market moves and raising questions ...
Massive AI budgets are on the horizon. This article breaks down who will spend the most, why the opportunity matters,...
A major investor stepped into Crocs with a sizable new stake, valuing the position at about $53.7 million even as CRO...
In quarterly 13F disclosures, billionaire loeb sold shares of major AI players while adding to a smaller AI stock tha...
Investors are weighing how legal rulings against Meta could reshape risk and earnings. This guide breaks down what ha...
A World Economic Forum analysis shows women’s health receives only 20% of global R&D funding, leaving a $1 trillion o...
Four mega-cap stocks are emerging as the most-watched potential split candidates after notable 2026 moves. ASML, GE V...